Table 4 Achievement of treatment target (HbA1c < 7% or 53 mmol/mol) by the changes in use of glucose lowering medication
Changes in the use of glucose lowering medication | Overall achievement of treatment target | |||
|---|---|---|---|---|
Intensification of medication | No change in medication | De-intensification of medication | ||
Patient categories: a | ||||
T2D only | (n = 530) | (n = 2409) | (n = 111) | (n = 3050) |
Proportion of patients undergoing changes in glucose medication, % | 17.4 | 79.0 | 3.6 | |
Target met 2011-12, % | 83.0 | 74.0 | 93.7 | 76.3 |
Target met 2015-16, % | 63.4 | 68.1 | 87.4 | 68.0 |
Change in achievement of treatment target (%) | -19.6 | -5.9 | -6.3 | -8.3 |
T2D + CVD | (n = 363) | (n = 1493) | (n = 110) | (n = 1966) |
Proportion of patients undergoing changes in glucose medication, % | 18.5 | 75.9 | 5.6 | |
Target met 2011-12, % | 81.3 | 67.9 | 90.0 | 71.3 |
Target met 2015-16, % | 63.4 | 60.4 | 89.1 | 62.6 |
Change in achievement of treatment target (%) | -17.9 | -7.5 | -0.9 | -8.7 |
T2D + AMD | (n = 127) | (n = 508) | (n = 40) | (n = 675) |
Proportion of patients undergoing changes in glucose medication, % | 18.8 | 75.3 | 5.9 | |
Target met 2011-12, % | 88.2 | 68.7 | 95.0 | 73.9 |
Target met 2015-16, % | 66.9 | 61.0 | 80.0 | 63.3 |
Change in achievement of treatment target (%) | -21.3 | -7.7 | -15.0 | -10.6 |
T2D + CVD + AMD | (n = 57) | (n = 290) | (n = 32) | (n = 379) |
Proportion of patients undergoing changes in glucose medication, % | 15.0 | 76.5 | 8.4 | |
Target met 2011-12, % | 78.9 | 64.5 | 87.5 | 68.6 |
Target met 2015-16, % | 56.1 | 59.0 | 84.4 | 60.7 |
Change in achievement of treatment target (%) | -22.8 | -5.5 | -3.1 | -7.9 |
P-value b | 0.683 | 0.835 | 0.157 | 0.712 |